Literature DB >> 28598844

Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.

Angélica González-Maciel1, Rafael Reynoso-Robles1, Ricardo Torres-Jardón2, Partha S Mukherjee3, Lilian Calderón-Garcidueñas4,5.   

Abstract

Millions of children and young adults are exposed to fine particulate matter (PM2.5) and ozone, associated with Alzheimer's disease (AD) risk. Mexico City (MC) children exhibit systemic and brain inflammation, low cerebrospinal fluid (CSF) Aβ1-42, breakdown of nasal, olfactory, alveolar-capillary, duodenal, and blood-brain barriers, volumetric and metabolic brain changes, attention and short-term memory deficits, and hallmarks of AD and Parkinson's disease. Airborne iron-rich strongly magnetic combustion-derived nanoparticles (CDNPs) are present in young urbanites' brains. Using transmission electron microscopy, we documented CDNPs in neurons, glia, choroid plexus, and neurovascular units of young MC residents versus matched clean air controls. CDNPs are associated with pathology in mitochondria, endoplasmic reticulum (ER), mitochondria-ER contacts (MERCs), axons,and dendrites. There is a significant difference in size and numbers between spherical CDNPs (>85%) and the angular, euhedral endogenous NPs (<15%). Spherical CDNPs (dogs 21.2±7.1 nm in diameter versus humans 29.1±11.2 nm, p = 0.002) are present in neurons, glia, choroid plexus, endothelium, nasal and olfactory epithelium, and in CSF at significantly higher in numbers in MC residents (p < 0.0001). Degenerated MERCs, abnormal mitochondria, and dilated ER are widespread, and CDNPs in close contact with neurofilaments, glial fibers, and chromatin are a potential source for altered microtubule dynamics, mitochondrial dysfunction, accumulation and aggregation of unfolded proteins, abnormal endosomal systems, altered insulin signaling, calcium homeostasis, apoptotic signaling, autophagy, and epigenetic changes. Highly oxidative, ubiquitous CDNPs constitute a novel path into AD pathogenesis. Exposed children and young adults need early neuroprotection and multidisciplinary prevention efforts to modify the course of AD at early stages.

Entities:  

Keywords:  Air pollution; Alzheimer’s disease; Mexico City; brain damage; children; electron microscopy; epigenetics; magnetite; mitochondria–ER contacts; nanoparticles; oxidative damage; ultrafine particulate matter

Mesh:

Substances:

Year:  2017        PMID: 28598844     DOI: 10.3233/JAD-170012

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

1.  The Impact of Inhaled Ambient Ultrafine Particulate Matter on Developing Brain: Potential Importance of Elemental Contaminants.

Authors:  Deborah A Cory-Slechta; Marissa Sobolewski; Elena Marvin; Katherine Conrad; Alyssa Merrill; Tim Anderson; Brian P Jackson; Gunter Oberdorster
Journal:  Toxicol Pathol       Date:  2019-10-14       Impact factor: 1.902

Review 2.  Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia.

Authors:  Minos Kritikos; Samuel E Gandy; Jaymie R Meliker; Benjamin J Luft; Sean A P Clouston
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 3.  Cognitive impairment and World Trade Centre-related exposures.

Authors:  Sean A P Clouston; Charles B Hall; Minos Kritikos; David A Bennett; Steven DeKosky; Jerri Edwards; Caleb Finch; William C Kreisl; Michelle Mielke; Elaine R Peskind; Murray Raskind; Marcus Richards; Richard P Sloan; Avron Spiro; Neil Vasdev; Robert Brackbill; Mark Farfel; Megan Horton; Sandra Lowe; Roberto G Lucchini; David Prezant; Joan Reibman; Rebecca Rosen; Kacie Seil; Rachel Zeig-Owens; Yael Deri; Erica D Diminich; Bernadette A Fausto; Sam Gandy; Mary Sano; Evelyn J Bromet; Benjamin J Luft
Journal:  Nat Rev Neurol       Date:  2021-11-18       Impact factor: 42.937

4.  Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet.

Authors:  Usa Suwannasual; JoAnn Lucero; Jacob D McDonald; Amie K Lund
Journal:  Environ Res       Date:  2017-11-05       Impact factor: 6.498

Review 5.  Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands.

Authors:  Laura Blaikie; Graeme Kay; Paul Kong Thoo Lin
Journal:  Medchemcomm       Date:  2019-10-16       Impact factor: 3.597

6.  Traffic-related air pollutants (TRAP-PM) promote neuronal amyloidogenesis through oxidative damage to lipid rafts.

Authors:  Mafalda Cacciottolo; Todd E Morgan; Arian A Saffari; Farimah Shirmohammadi; Henry Jay Forman; Costantinos Sioutas; Caleb E Finch
Journal:  Free Radic Biol Med       Date:  2019-12-26       Impact factor: 7.376

7.  Exposure to traffic-generated air pollution promotes alterations in the integrity of the brain microvasculature and inflammation in female ApoE-/- mice.

Authors:  Anna Adivi; JoAnn Lucero; Nicholas Simpson; Jacob D McDonald; Amie K Lund
Journal:  Toxicol Lett       Date:  2020-12-26       Impact factor: 4.372

8.  The Effects of Chronic Exposure to Ambient Traffic-Related Air Pollution on Alzheimer's Disease Phenotypes in Wildtype and Genetically Predisposed Male and Female Rats.

Authors:  Kelley T Patten; Anthony E Valenzuela; Christopher Wallis; Elizabeth L Berg; Jill L Silverman; Keith J Bein; Anthony S Wexler; Pamela J Lein
Journal:  Environ Health Perspect       Date:  2021-05-10       Impact factor: 9.031

Review 9.  Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective.

Authors:  Molly Fox; Delaney A Knorr; Kacey M Haptonstall
Journal:  Ann N Y Acad Sci       Date:  2019-06-10       Impact factor: 6.499

Review 10.  Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.

Authors:  Owen Sanders; Lekshmy Rajagopal
Journal:  J Alzheimers Dis Rep       Date:  2020-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.